When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA Issues Warning Letters Against Online GLP 1 Sellers BioSpace Is BPC 157 Banned? Oral vs. Injectable Forms Explained On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Warning Letter to Platinum Biologics LLC for marketing umbilicalcordderived products including exosome products (NanoEx & Nano Xsomes) without approval. Big FDA review coming this July. Here's what athletes and patients should know about BPC 157, TB 500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 # When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions